Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DEPO

Depomed (DEPO) Stock Price, News & Analysis

Depomed logo

About Depomed Stock (NASDAQ:DEPO)

Advanced Chart

Key Stats

Today's Range
$7.09
$7.42
50-Day Range
N/A
52-Week Range
$4.31
$9.48
Volume
940,193 shs
Average Volume
1.30 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DEPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Depomed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DEPO Stock News Headlines

Pfizer: Investor Activism Is Not The Solution
Elon Musk’s New Technology
Elon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a new AI supercomputer—what one industry CEO calls “the most powerful in the world.” Musk says this tech will drive the next wave of American innovation. You can’t invest in the supercomputer directly—but there’s a backdoor way to access the company powering it. It’s smaller than Tesla or Nvidia, but both rely on it for future growth.tc pixel
Why DepoMed (DEPO) Stock Is Gaining Today
Opioid Litigants Get Boost From Senate Report
See More Headlines

DEPO Stock Analysis - Frequently Asked Questions

Depomed, Inc. (NASDAQ:DEPO) issued its quarterly earnings results on Wednesday, August, 8th. The specialty pharmaceutical company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.16 by $0.03. Depomed's revenue was down 37.0% compared to the same quarter last year.

Company Calendar

Last Earnings
8/08/2018
Today
8/26/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:DEPO
CIK
1005201
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:DEPO) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners